Skip to main content
Skip to main content

Third-Party COA vs Manufacturer COA

What actually changes between a COA the seller writes and a COA an independent lab writes — and when each one is enough.

The core difference

A manufacturer COA is written by the party that produced the peptide. A third-party COA is written by a lab with no commercial interest in whether the batch passes or fails. Both may use HPLC and mass spectrometry. What differs is who is on the hook for the number.

What each one guarantees

  • Manufacturer COA — the producer's internal QC found the batch to meet their published spec, using their methods on their instruments.
  • Third-party COA — an accredited, independent lab measured the sample against its own validated methods and reference standards, and the result is auditable.

When third-party testing is required, not optional

  • 503A/503B compounding pharmacies dispensing peptide preparations
  • Clinical-grade research where data will be submitted or audited
  • Litigation, regulatory response, or supplier disputes
  • Onboarding a new peptide supplier — baseline verification before scale

What to look for on any COA

Both COA types should include HPLC chromatogram, mass spectrum, method parameters, reference standards, sample chain of custody, and a signature. If any of those are missing, treat the COA as incomplete. See how to read a peptide COA.

Cost delta

The manufacturer COA is bundled into the peptide price. Third-party HPLC purity starts at $150 per sample and full contaminant panels run $500–$1,200. On a batch worth thousands of dollars downstream, that's a small line item. See peptide purity testing cost for the full breakdown.

Related reading

Frequently asked questions

Frequently Asked Questions

A manufacturer COA is a document supplied by the peptide producer stating the tested purity, identity, and specifications of the batch. It is generated by the same party selling the product.

A third-party COA is generated by an independent analytical lab with no commercial interest in the batch. The lab tests a sample using its own validated methods and reports the result directly to the requester.

Not automatically. A well-run manufacturer with a validated QC program produces reliable COAs. The issue is that you have no way to distinguish those from COAs produced under weaker controls. Third-party verification is how you separate them.

Our lab data shows measurable discrepancies between claimed and measured purity on a significant share of samples that arrive with a manufacturer COA. For anything intended for regulated use, that gap is why independent testing exists.

For research use, a third-party COA on incoming lots is often sufficient. For 503A/503B compounding pharmacies and clinical use, third-party testing on top of a manufacturer COA is standard practice.

An independent third-party COA with raw chromatographic data is more defensible than a manufacturer COA alone. The accreditation, method validation, and independence are what make it hold up.